Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir.
Guo W, Wong S, Pudney J, Jasuja R, Hua N, Jiang L, Miller A, Hruz PW, Hamilton JA, Bhasin S.
Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2028-32. Epub 2009 Sep 17.PMID: 19762785 [PubMed - in process]Related articles